AngioDynamics Property Plant and Equipment Net vs Debt Non Current Analysis

ANGO Stock  USD 5.70  0.30  5.56%   
Trend analysis of AngioDynamics balance sheet accounts such as Total Assets of 533.4 M, Short and Long Term Debt Total of 66.3 M or Other Current Liab of 52.4 M provides information on AngioDynamics' total assets, liabilities, and equity, which is the actual value of AngioDynamics to its prevalent stockholders. By breaking down trends over time using AngioDynamics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

About AngioDynamics Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of AngioDynamics at a specified time, usually calculated after every quarter, six months, or one year. AngioDynamics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of AngioDynamics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which AngioDynamics currently owns. An asset can also be divided into two categories, current and non-current.

AngioDynamics Balance Sheet Chart

AngioDynamics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how AngioDynamics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, AngioDynamics' Other Current Assets are very stable compared to the past year. As of the 28th of March 2024, Non Currrent Assets Other is likely to grow to about 65.6 M, while Common Stock Shares Outstanding is likely to drop about 29.4 M.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of AngioDynamics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AngioDynamics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from AngioDynamics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AngioDynamics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.As of the 28th of March 2024, Discontinued Operations is likely to grow to about 87.5 M, while Selling General Administrative is likely to drop about 27.5 M.
 2021 2022 2023 2024 (projected)
Gross Profit165.7M174.2M200.4M129.6M
Total Revenue316.2M338.8M389.6M242.9M

AngioDynamics fundamental ratios Correlations

0.660.10.360.880.70.520.1-0.15-0.310.440.310.580.160.10.270.70.95-0.340.260.78-0.080.960.50.480.63
0.660.780.090.670.990.730.280.330.390.260.350.970.10.780.360.760.770.160.840.760.360.730.920.480.72
0.10.78-0.170.270.680.630.180.660.750.030.130.810.010.990.150.560.240.390.950.430.540.190.890.30.4
0.360.09-0.170.50.110.1-0.66-0.38-0.590.80.31-0.050.18-0.130.330.320.37-0.15-0.140.120.010.40.040.080.44
0.880.670.270.50.660.65-0.120.02-0.260.610.260.580.170.280.250.870.9-0.080.340.760.170.910.610.590.66
0.70.990.680.110.660.660.350.210.320.250.410.940.150.690.420.720.810.140.750.750.310.770.840.460.77
0.520.730.630.10.650.66-0.20.710.130.44-0.30.820.20.63-0.30.880.630.310.710.820.540.610.80.780.2
0.10.280.18-0.66-0.120.35-0.2-0.160.53-0.640.430.25-0.140.170.4-0.190.08-0.070.17-0.02-0.220.050.11-0.080.28
-0.150.330.66-0.380.020.210.71-0.160.44-0.01-0.650.52-0.010.64-0.640.43-0.020.480.650.40.59-0.060.560.45-0.34
-0.310.390.75-0.59-0.260.320.130.530.44-0.570.190.43-0.20.740.19-0.02-0.230.330.67-0.080.26-0.280.49-0.10.13
0.440.260.030.80.610.250.44-0.64-0.01-0.570.010.190.40.070.050.60.50.020.050.460.350.520.240.390.35
0.310.350.130.310.260.41-0.30.43-0.650.190.010.130.00.161.00.00.28-0.240.1-0.1-0.240.280.17-0.30.85
0.580.970.81-0.050.580.940.820.250.520.430.190.130.080.80.130.760.70.220.890.790.40.650.940.550.53
0.160.10.010.180.170.150.2-0.14-0.01-0.20.40.00.080.060.030.170.220.15-0.070.150.190.22-0.010.070.12
0.10.780.99-0.130.280.690.630.170.640.740.070.160.80.060.180.550.260.440.940.430.570.20.890.270.43
0.270.360.150.330.250.42-0.30.4-0.640.190.051.00.130.030.180.00.27-0.180.11-0.11-0.20.270.17-0.30.85
0.70.760.560.320.870.720.88-0.190.43-0.020.60.00.760.170.550.00.790.140.60.850.510.770.780.750.5
0.950.770.240.370.90.810.630.08-0.02-0.230.50.280.70.220.260.270.79-0.040.360.870.151.00.590.550.68
-0.340.160.39-0.15-0.080.140.31-0.070.480.330.02-0.240.220.150.44-0.180.14-0.040.250.120.71-0.060.180.17-0.07
0.260.840.95-0.140.340.750.710.170.650.670.050.10.89-0.070.940.110.60.360.250.550.420.310.960.350.41
0.780.760.430.120.760.750.82-0.020.4-0.080.46-0.10.790.150.43-0.110.850.870.120.550.430.850.70.630.41
-0.080.360.540.010.170.310.54-0.220.590.260.35-0.240.40.190.57-0.20.510.150.710.420.430.130.410.320.09
0.960.730.190.40.910.770.610.05-0.06-0.280.520.280.650.220.20.270.771.0-0.060.310.850.130.550.550.68
0.50.920.890.040.610.840.80.110.560.490.240.170.94-0.010.890.170.780.590.180.960.70.410.550.480.55
0.480.480.30.080.590.460.78-0.080.45-0.10.39-0.30.550.070.27-0.30.750.550.170.350.630.320.550.480.12
0.630.720.40.440.660.770.20.28-0.340.130.350.850.530.120.430.850.50.68-0.070.410.410.090.680.550.12
Click cells to compare fundamentals

AngioDynamics Account Relationship Matchups

AngioDynamics fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding38.0M38.3M39.0M39.5M45.4M29.4M
Total Assets595.5M561.4M552.8M532.6M612.5M533.4M
Short Long Term Debt Total40.8M20M33.8M49.8M57.3M66.3M
Other Current Liab2.1M38.0M21.5M43.4M49.9M52.4M
Total Current Liabilities51.5M57.6M74.3M83.8M96.4M48.7M
Total Stockholder Equity455.9M439.5M424.5M378.3M435.0M404.2M
Property Plant And Equipment Net28.3M37.1M45.0M44.4M51.0M35.0M
Net Debt(13.6M)(28.2M)5.0M5.2M6.0M5.7M
Retained Earnings(100.3M)(131.9M)(158.4M)(210.9M)(189.8M)(180.3M)
Accounts Payable19.1M19.6M28.0M40.4M46.5M48.8M
Cash54.4M48.2M28.8M44.6M51.3M45.7M
Non Current Assets Total442.6M420.6M409.4M369.1M424.5M382.2M
Other Assets5.2M3.8M11.0M49.2M56.6M59.4M
Long Term Debt40M20M25M49.8M57.3M58.7M
Cash And Short Term Investments54.4M48.2M28.8M44.6M51.3M61.7M
Net Receivables31.3M35.4M52.3M52.8M60.7M38.3M
Common Stock Total Equity374K377K380K382K439.3K308.9K
Liabilities And Stockholders Equity595.5M561.4M552.8M532.6M612.5M533.4M
Non Current Liabilities Total88.1M64.4M53.9M70.5M81.1M80.5M
Inventory59.9M48.6M51.4M55.3M63.6M42.5M
Other Current Assets2.2M1.8M2.2M4.6M4.2M4.5M
Other Stockholder Equity557.2M567.8M581.2M593.5M682.5M424.4M
Total Liab139.6M122.0M128.3M154.3M177.5M129.1M
Property Plant And Equipment Gross28.3M37.1M96.1M44.4M51.0M37.5M
Total Current Assets152.9M140.9M143.3M163.5M188.1M151.2M
Accumulated Other Comprehensive Income(1.3M)3.2M1.4M(4.7M)(5.4M)(5.2M)
Short Term Debt836K2.4M8.8M14.8M17.0M8.5M
Intangible Assets197.1M169.0M152.4M111.1M127.8M113.3M
Common Stock374K377K380K382K439.3K309.7K
Property Plant Equipment28.3M37.1M45.0M44.4M51.0M34.9M
Non Currrent Assets Other15.6M13.2M(5.1M)54.3M62.5M65.6M
Other Liab39.6M37.1M24.2M17.4M20.0M32.6M
Good Will201.5M201.3M201.1M159.2M183.1M283.9M
Net Tangible Assets57.2M69.2M71.1M378.3M435.0M456.8M
Retained Earnings Total Equity(100.3M)(131.9M)(158.4M)(210.9M)(189.8M)(180.3M)
Long Term Debt Total40M20M25M49.8M44.8M69.2M
Capital Surpluse561.9M573.5M586.9M599.2M689.1M600.4M
Deferred Long Term Liab24.1M20.0M16.0M12.8M14.7M14.1M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AngioDynamics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AngioDynamics' short interest history, or implied volatility extrapolated from AngioDynamics options trading.

Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

Moving together with AngioDynamics Stock

  0.62MBOT Microbot Medical Earnings Call TomorrowPairCorr
  0.7DH Definitive Healthcare Financial Report 2nd of May 2024 PairCorr
  0.8CMAXW CareMaxPairCorr

Moving against AngioDynamics Stock

  0.73CAH Cardinal Health Financial Report 2nd of May 2024 PairCorr
  0.66NYXH Nyxoah Financial Report 21st of May 2024 PairCorr
  0.52FEMY Femasys Report 4th of April 2024 PairCorr
  0.41AHG Akso Health GroupPairCorr
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.36)
Revenue Per Share
8.28
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.03)
Return On Equity
(0.03)
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.